Holen Sie sich die Stockscreener-App
61.71
1.05%
0.64
Handel nachbörslich:
61.71
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt CTVA?
Forum
Prognose
Dividendenhistorie
Schlusskurs vom Vortag:
$61.07
Offen:
$61.18
24-Stunden-Volumen:
3.77M
Relative Volume:
1.08
Marktkapitalisierung:
$40.43B
Einnahmen:
$16.91B
Nettoeinkommen (Verlust:
$907.00M
KGV:
47.84
EPS:
1.29
Netto-Cashflow:
$1.55B
1W Leistung:
+3.30%
1M Leistung:
-0.58%
6M Leistung:
+1.53%
1J Leistung:
+12.67%
1-Tages-Spanne:
$60.79
$61.90
1-Wochen-Bereich:
$58.58
$62.25
52-Wochen-Spanne:
$50.01
$66.24
Corteva Inc Stock (CTVA) Company Profile
Firmenname
Corteva Inc
Sektor
Branche
Telefon
(833) 267-8382
Adresse
9330 ZIONSVILLE ROAD, INDIANAPOLIS, DE
Vergleichen Sie CTVA mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
CTVA
Corteva Inc
|
61.71 | 40.43B | 16.91B | 907.00M | 1.55B | 1.29 |
|
NTR
Nutrien Ltd
|
53.68 | 26.03B | 25.97B | 674.00M | 1.38B | 1.37 |
|
CF
Cf Industries Holdings Inc
|
77.30 | 12.63B | 5.98B | 1.16B | 1.82B | 6.32 |
|
MOS
Mosaic Company
|
28.93 | 8.56B | 11.46B | 371.20M | 301.40M | 1.13 |
|
ICL
Icl Group Ltd
|
6.67 | 8.14B | 6.93B | 404.00M | 652.00M | 0.31 |
Corteva Inc Stock (CTVA) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-03-31 | Hochstufung | Argus | Hold → Buy |
| 2025-03-13 | Eingeleitet | Goldman | Buy |
| 2024-10-23 | Eingeleitet | Citigroup | Buy |
| 2024-10-16 | Hochstufung | BofA Securities | Neutral → Buy |
| 2024-08-07 | Herabstufung | Argus | Buy → Hold |
| 2024-04-12 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2024-03-01 | Eingeleitet | Wolfe Research | Outperform |
| 2024-02-12 | Hochstufung | Loop Capital | Hold → Buy |
| 2024-02-02 | Hochstufung | Exane BNP Paribas | Underperform → Neutral |
| 2023-11-27 | Herabstufung | Berenberg | Buy → Hold |
| 2023-11-14 | Herabstufung | Barclays | Overweight → Equal Weight |
| 2023-10-20 | Hochstufung | Oppenheimer | Perform → Outperform |
| 2023-09-05 | Hochstufung | UBS | Neutral → Buy |
| 2023-07-25 | Herabstufung | Redburn | Buy → Neutral |
| 2023-06-28 | Eingeleitet | Canaccord Genuity | Buy |
| 2023-05-22 | Hochstufung | Vertical Research | Hold → Buy |
| 2023-04-06 | Eingeleitet | Oppenheimer | Perform |
| 2023-01-19 | Eingeleitet | Wells Fargo | Overweight |
| 2023-01-11 | Hochstufung | BofA Securities | Underperform → Neutral |
| 2022-11-16 | Herabstufung | UBS | Buy → Neutral |
| 2022-11-15 | Herabstufung | Loop Capital | Buy → Hold |
| 2022-08-08 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2022-08-08 | Hochstufung | ROTH Capital | Neutral → Buy |
| 2022-07-14 | Eingeleitet | Credit Suisse | Outperform |
| 2022-06-01 | Eingeleitet | Barclays | Overweight |
| 2022-05-06 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2022-04-14 | Hochstufung | Loop Capital | Hold → Buy |
| 2022-04-14 | Herabstufung | Vertical Research | Buy → Hold |
| 2022-01-31 | Hochstufung | Redburn | Neutral → Buy |
| 2021-10-18 | Herabstufung | Loop Capital | Buy → Hold |
| 2021-10-13 | Eingeleitet | Mizuho | Buy |
| 2021-10-08 | Eingeleitet | ROTH Capital | Buy |
| 2021-09-01 | Eingeleitet | Berenberg | Buy |
| 2021-08-09 | Hochstufung | Monness Crespi & Hardt | Sell → Neutral |
| 2021-05-10 | Herabstufung | BofA Securities | Buy → Underperform |
| 2021-04-19 | Hochstufung | Loop Capital | Hold → Buy |
| 2021-02-05 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2021-02-05 | Bestätigt | Monness Crespi & Hardt | Sell |
| 2020-12-18 | Herabstufung | Susquehanna | Positive → Neutral |
| 2020-12-14 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2020-11-10 | Hochstufung | Argus | Hold → Buy |
| 2020-10-19 | Hochstufung | BofA Securities | Neutral → Buy |
| 2020-10-19 | Herabstufung | Exane BNP Paribas | Outperform → Underperform |
| 2020-08-11 | Hochstufung | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2020-08-10 | Herabstufung | BofA Securities | Buy → Neutral |
| 2020-07-13 | Hochstufung | BofA Securities | Underperform → Buy |
| 2020-06-26 | Eingeleitet | Cleveland Research | Neutral |
| 2020-06-16 | Hochstufung | Vertical Research | Hold → Buy |
| 2020-06-08 | Herabstufung | Monness Crespi & Hardt | Neutral → Sell |
| 2020-05-11 | Herabstufung | BofA/Merrill | Neutral → Underperform |
| 2020-04-17 | Herabstufung | BofA/Merrill | Buy → Neutral |
| 2020-04-17 | Hochstufung | Loop Capital | Sell → Hold |
| 2020-04-01 | Hochstufung | Exane BNP Paribas | Neutral → Outperform |
| 2020-03-31 | Hochstufung | Susquehanna | Neutral → Positive |
| 2020-03-26 | Eingeleitet | KeyBanc Capital Markets | Sector Weight |
| 2020-03-19 | Hochstufung | Edward Jones | Hold → Buy |
| 2020-03-13 | Hochstufung | BofA/Merrill | Neutral → Buy |
| 2020-03-10 | Hochstufung | Monness Crespi & Hardt | Sell → Neutral |
Alle ansehen
Corteva Inc Aktie (CTVA) Neueste Nachrichten
Rely on Relationships for Success This Season - AgWeb
Corteva's Q1 2025 Earnings: What to Expect - inkl
Corteva's Q1 2025 Earnings: What To Expect - Barchart.com
Corteva invests in Puna Bio’s natural agricultural innovations - World Bio Market Insights
Puna Bio receives investment from Corteva Catalyst - Agro Spectrum India
Here's How Much $1000 Invested In Corteva 5 Years Ago Would Be Worth Today - Benzinga
Puna Bio receives investment from Corteva Catalyst | CTVA Stock News - GuruFocus
Corteva Invests in Desert Bacteria Startup That Boosted Crop Yields 15% Across 800,000 Acres - Stock Titan
Sustainable Agriculture Market in 2025: Trends Shaping - openPR.com
Lobbying Update: $1,360,000 of CORTEVA AGRISCIENCE LLC (FKA E I DU PONT DE NEMOURS AND COMPANY) lobbying was just disclosed - Nasdaq
Corteva: Upgraded To Strong Buy On Tariffs, Currency Tailwinds, Strong Guidance - Seeking Alpha
Corteva, Under Activist Pressure, Forecasts Big Rise in Profits - WSJ
Sunflower Seeds Market to Witness Remarkable Growth With Corteva, Inc., Groupe Limagrain, Kws Saat Se & Co. Kga - openPR.com
Corteva and Indiana State Fairgrounds celebrate unveiling of Corteva Coliseum - WBIW
$1000 Invested In Corteva 5 Years Ago Would Be Worth This Much Today - Benzinga
Sweet Corn Seeds Market Rapidly Increasing Worldwide CAGR - openPR.com
Genetically Modified Crops Market Key Players, Industry - openPR.com
KeyBanc Lifts Corteva (CTVA) Price Target Amid Tariff Concerns | CTVA Stock News - GuruFocus
Turnrow Talk: Relationships Drive Success - AgWeb
Corteva To Rally Around 20%? Here Are 10 Top Analyst Forecasts For Monday - Benzinga
KeyBanc Lifts Corteva (CTVA) Price Target Amid Tariff Concerns | - GuruFocus
Zacks Industry Outlook Corteva, Dole, Adecoagro and Mission Produce - Yahoo Finance
Best Agriculture Stocks Worth WatchingApril 9th - MarketBeat
Corteva Agriscience employees in Johnston face layoff - MSN
BNP Paribas Exane Adjusts Price Target on Corteva to $59 From $60 - marketscreener.com
Specialty Pesticides Market is Thriving Worldwide | Bayer AG, Syngenta AG, Corteva Agriscience, BASF SE - openPR.com
Corteva (NYSE:CTVA) Projects Positive Earnings Guidance - Yahoo Finance
Decoding Mission Produce's High P/E: Bargain Buy or Overpriced Risk? - TradingView
Why Corteva, Inc. (CTVA) is the Best Farmland and Agriculture Stock to Buy Now - Yahoo Finance
We Like These Underlying Return On Capital Trends At Corteva (NYSE:CTVA) - Yahoo Finance
Trending Opportunities in the Crop Protection Chemicals Market - openPR.com
Yuba Grower Named 2024 Rice Consultant of the Year - AgNet West
14 Best Farmland and Agriculture Stocks Buy Now - Insider Monkey
Jefferies Adjusts Corteva's Price Target to $72 From $74, Keeps Buy Rating - marketscreener.com
UBS Adjusts Price Target on Corteva to $74 From $73, Keeps Buy Rating - MarketScreener
Possible Bearish Signals With Corteva Insiders Disposing Stock - simplywall.st
Corteva confirms layoffs in Johnston, Iowa - Ottumwa Radio
Corteva Agriscience Lays Off Over Forty Employees - newsradio 1040 who
Corteva in Johnston to lay off dozens of workers - WHO13.com
For Agriculture Inputs, We See Small Impact from Tariffs, as Costs Are Largely Passed Along to Farmers - Morningstar
Corteva upgraded at Argus Research on improved demand trends - MSN
Corteva Cumulative Preferred Stock About To Put More Money In Your Pocket - Nasdaq
Argus Research Upgrades Corteva (DB:2X0) - Nasdaq
Corteva upgraded to Buy at Argus on improving fundamentals, stabilizing prices - Yahoo Finance
Goldman Sachs Adjusts Price Target on Corteva to $73 From $71, Keeps Buy Rating - MarketScreener
Argus Upgrades Corteva Inc to Buy From Hold, Price Target is $69 - MarketScreener
Company unveils game-changing non-GMO seed that could solve growing global crisis: 'Revolutionary benefits' - MSN
Argus Research Upgrades Corteva (LSE:0A1W) - Nasdaq
Argus Research Upgrades Corteva (CTVA) - Nasdaq
The Analyst Verdict: Corteva In The Eyes Of 11 Experts - Benzinga
Argus Research Upgrades Corteva (BMV:CTVA) - Nasdaq
Finanzdaten der Corteva Inc-Aktie (CTVA)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.13%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):